Premature Ejaculation: Causes and Evidence-Based Treatment

Premature ejaculation (ejaculatio praecox) is usually defined as persistent or recurrent ejaculation occurring with minimal sexual stimulation, sooner than a man would wish, accompanied by distress or avoidance of intimacy. Clinical trials often use a specific parameter — intravaginal ejaculatory latency time (IELT), measured with a stopwatch, where a value under 1–2 minutes in most encounters is often treated as a diagnostic criterion for the lifelong form of the condition.

Although the problem affects a large share of men at some point in life, it reaches a doctor's office far less often than erectile dysfunction — partly because it's mistakenly treated as a matter of character or skill rather than a condition with a documented neurobiological basis and real, well-studied treatment options. That misconception is itself a source of additional distress, since it leads to avoiding the conversation instead of seeking help.

The leading neurobiological hypothesis links premature ejaculation to reduced sensitivity of certain serotonin receptors (5-HT2C) in the central nervous system, which shortens the time needed to reach the ejaculatory threshold. This explains why drugs that increase serotonin availability at the synapse — selective serotonin reuptake inhibitors (SSRIs) — are among the most effective pharmacological tools for this condition, even though their original indication is treating depression and anxiety disorders.

Alongside the neurobiological mechanism, psychological factors play a significant role: fear of a partner's judgment, earlier negative sexual experiences reinforcing a pattern of rushing, general anxiety and stress levels (described in more detail in our entry on chronic stress), and erectile dysfunction, which paradoxically leads to faster ejaculation out of fear of losing the erection. These two levels — biological and psychological — aren't mutually exclusive, and in clinical practice they most often coexist, reinforcing each other.

Unlike other SSRIs, dapoxetine was developed from the ground up to treat premature ejaculation rather than depression — it has a short half-life and is taken on demand, 1–3 hours before planned intercourse, rather than daily. This sets it apart from classic SSRIs, which accumulate in the body with continuous use and have a much longer duration of action.

In countries where dapoxetine isn't registered or available, doctors sometimes prescribe classic, daily-use SSRIs off-label — most often paroxetine, sertraline, fluoxetine, or clomipramine (a tricyclic drug acting similarly on the serotonin system). Unlike dapoxetine, these drugs require daily use for several weeks before the effect fully stabilizes, and they aren't approved for this indication, which requires an informed decision by both doctor and patient about off-label therapy.

Behavioral techniques such as the stop-start method (interrupting stimulation just before ejaculation and resuming once arousal subsides) or the squeeze technique (gently squeezing the glans as ejaculation approaches) have been recommended for decades as a non-pharmacological treatment option, often as part of broader sex therapy or couples' psychotherapy.

A second widespread myth is the belief that the only effective solution is a daily antidepressant for the rest of one's life — in practice, dapoxetine (taken on demand) and behavioral therapy offer a real alternative or complement, matched to the patient's preferences and frequency of sexual activity.

Premature ejaculation is one of those areas of sexual medicine where the scientific evidence clearly diverges from the common perception of the problem as a matter of character. The reality is more complex and more encouraging: there's a drug designed specifically for this indication with solid data from a trial of over a thousand men, there's an alternative in classic SSRIs, and behavioral therapy, despite its evidentiary limitations, makes sense as a complement, especially where anxiety plays a strong role. The key is treating the problem as a medical condition worth discussing with a doctor, not a taboo topic.